Skip to main content
Livermore
Livermore
ZHEN

Kiromic Biopharma, Inc.

KRBPDelisted Nov 20, 2023
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001792581

Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.

Holders of 5% or more of KRBP

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kiromic Biopharma, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Kiromic Biopharma, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

12 Schedule 13D and 13G filings on Kiromic Biopharma, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on KRBP
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 4, 2024YA II PN, Ltd.13G/AOld format–––SEC
May 20, 2024Ralston Shannon13DOld format–New–SEC
May 9, 2024Bersani Pietro13D/AOld format–––SEC
Feb 12, 2024YA II PN, Ltd.13G/AOld format–––SEC
Feb 8, 2024Bersani Pietro13DOld format–New–SEC
Jan 8, 2024Empery Asset Management, LP13G/AOld format–––SEC
Jan 2, 2024Sabby Management, LLC13G/AOld format–––SEC
Jan 12, 2023Empery Asset Management, LP13GOld format–––SEC
Jan 4, 2023Sabby Management, LLC13GOld format–New–SEC
Oct 20, 2022YA II PN, Ltd.13GOld format–New–SEC
Jan 13, 2022Empery Asset Management, LP13G/AOld format–––SEC
Jul 6, 2021Empery Asset Management, LP13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Kiromic Biopharma, Inc. shares.

No Form 144 notices for Kiromic Biopharma, Inc. are on file.